View Older Stories View More Recent Stories

Feb 14, 2024 10:15AM Form SC 13G/A VALVOLINE INC Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2024 10:14AM Form SC 13G/A Viking Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2024 10:13AM Form SC 13G/A NewAmsterdam Pharma Co Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2024 10:11AM Form SC 13G/A Five9, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2024 10:00AM Form SC 13G/A Verastem, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2024 10:00AM Form SC 13G/A Inhibrx, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 13, 2024 07:27AM Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic Asthma
Feb 8, 2024 08:00AM Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders
Feb 5, 2024 04:30PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Jan 30, 2024 04:31PM Form SC 13G Oric Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP
Jan 24, 2024 07:00AM Ayana Bio and Wooree Green Science Partner to Develop Plant-Cell Derived Saffron for Health & Wellness Products
Jan 22, 2024 08:30AM ORIC Pharmaceuticals (ORIC) Prices 12.5M Share Offering at $10/sh
Jan 22, 2024 08:30AM ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
Jan 19, 2024 02:36PM Valsoft Corporation Raises Funding to Accelerate Growth in Vertical Market Software
Jan 9, 2024 04:47PM Form SC 13G STANDARD BIOTOOLS INC. Filed by: VIKING GLOBAL INVESTORS LP
Jan 8, 2024 04:15PM Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
Jan 8, 2024 04:05PM Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
Jan 5, 2024 05:45PM Form 4 4D Molecular Therapeutic For: Jan 04 Filed by: Viking Global Opportunities GP LLC
Jan 4, 2024 08:00AM HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases
Jan 2, 2024 09:56PM Form 144 APi Group Corp Filed by: VIKING GLOBAL INVESTORS LP
Dec 19, 2023 10:00AM Lightmatter Accelerates Growth and Expands Photonic Chip Deployments With $155M in New Funding; Now Valued at $1.2B
Dec 19, 2023 07:00AM Ayana Bio Welcomes Industry Veteran Jim Hamilton to its Board of Directors
Dec 12, 2023 05:31PM Madryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company’s Proposed Merger with Standard BioTools
Dec 12, 2023 11:45AM Battelle, Revive Environmental to Demonstrate PFAS Technology in Department of Defense Project
Dec 8, 2023 04:11PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Dec 8, 2023 09:00AM Alveolus Bio Enters Into Strategic Collaboration with BiomEdit
Nov 22, 2023 04:16PM Form SC 13D/A STANDARD BIOTOOLS INC. Filed by: VIKING GLOBAL INVESTORS LP
Nov 22, 2023 04:15PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Nov 22, 2023 04:15PM Form SC 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2023 03:10PM Form 13F-HR VIKING GLOBAL INVESTORS For: Sep 30
Nov 7, 2023 04:11PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Nov 2, 2023 04:33PM Form SC 13G Viking Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Oct 31, 2023 09:00AM Pearl Health Releases Annual Report and Survey Findings on the State of Primary Care
Oct 26, 2023 06:00AM Triveni Bio Launches with $92 Million Series A Financing to Advance Genetics-Informed Precision Medicines for the Treatment of Immunological and Inflammatory (I&I) Disorders
Oct 24, 2023 08:00AM DermBiont Announces First Close of $35.2 Million in a Series B Financing to Advance First-in-Class Targeted Topical Dermatological Therapeutics
Oct 23, 2023 07:00AM Ayana Bio Launches Plant Cell Advantage™ Portfolio with Three New Health and Wellness Ingredients
Oct 16, 2023 04:30PM Form SC 13D STANDARD BIOTOOLS INC. Filed by: VIKING GLOBAL INVESTORS LP
Oct 16, 2023 07:00AM Survey data reveals two-thirds of American adults would eat more and pay more for ultra-processed foods that include more nutritious ingredients
Oct 6, 2023 04:15PM Form SC 13G Five9, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Oct 6, 2023 07:36AM Form D/A Viking Global Opportunit
Oct 6, 2023 07:26AM Form D/A Viking Global Equities
Oct 6, 2023 07:18AM Form D/A Viking Global Opportunit
Oct 6, 2023 07:05AM Form D/A Viking Global Equities
Oct 6, 2023 06:55AM Form D/A Viking Global Equities
Sep 28, 2023 08:04AM AI startup AlphaSense valued at $2.5 billion after latest funding round
Sep 28, 2023 08:00AM AlphaSense Grows to $2.5 Billion Valuation, Securing $150 Million in Series E Funding Led by BOND
Sep 27, 2023 11:35AM Battelle Ranked Fifth on Fortune’s 2023 Change the World List for Its PFAS Annihilator® Technology
Sep 26, 2023 08:17AM Mythic Therapeutics Receives FDA Fast Track Designation for MYTX-011 for Patients with Non-Small Cell Lung Cancer (NSCLC) with cMET Overexpression
Sep 22, 2023 05:25PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Sep 21, 2023 05:11PM Form SC 13G RayzeBio, Inc. Filed by: VIKING GLOBAL INVESTORS LP
View More Recent Stories View Older Stories